Correction: Ruxolitinib Sensitizes Ovarian Cancer to Reduced Dose Taxol, Limits Tumor Growth and Improves Survival in Immune Competent Mice

Oncotarget - United States
doi 10.18632/oncotarget.25791
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

GML Sensitizes Cancer Cells to Taxol by Induction of Apoptosis

Oncogene
Cancer ResearchGeneticsMolecular Biology
1997English

Leptin Contributes to the Taxol Chemoresistance in Epithelial Ovarian Cancer

Oncology Letters
Cancer ResearchOncology
2019English

Blockade of TGF-β Signaling With Novel Synthetic Antibodies Limits Immune Exclusion and Improves Chemotherapy Response in Metastatic Ovarian Cancer Models

OncoImmunology
OncologyAllergyImmunology
2018English

Suppression of Mucin 2 Promotes Interleukin-6 Secretion and Tumor Growth in an Orthotopic Immune-Competent Colon Cancer Animal Model

Oncology Reports
MedicineCancer ResearchOncology
2014English

Trastuzumab Sensitizes Ovarian Cancer Cells to EGFR-targeted Therapeutics

Journal of Ovarian Research
GynecologyOncologyObstetrics
2010English

Kanglaite Sensitizes Colorectal Cancer Cells to Taxol via NF-κΒ Inhibition and Connexin 43 Upregulation

Scientific Reports
Multidisciplinary
2017English

Hormone-Receptor Expression and Ovarian Cancer Survival: An Ovarian Tumor Tissue Analysis Consortium Study

The Lancet Oncology
Oncology
2013English

Knockdown of Cathepsin�L Sensitizes Ovarian Cancer Cells to Chemotherapy

Oncology Letters
Cancer ResearchOncology
2016English

Smac Mimetic Increases Chemotherapy Response and Improves Survival in Mice With Pancreatic Cancer

Cancer Research
Cancer ResearchOncology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy